Our Products
Categories
Tags
Tesamorelin (10mg Vial)
Less visceral fat, more definition.
Tesamorelin is a synthetic 44–amino acid peptide, an analogue of GHRH, with an N-terminal modification for improved stability. In studies, it acts on GHRH receptors in the anterior pituitary, stimulating endogenous release of growth hormone (GH) and increasing IGF-1 systemically and also locally in various tissues, with effects investigated in metabolism and body composition.
Key Benefits
- Advanced support for reducing visceral fat
- Optimisation of body recomposition
- Improved metabolic efficiency and energy levels
- Support for tissue recovery and physiological performance
- Strong alignment with healthy ageing strategies
SLU-PP-332 (10mg Vial)
SLU-PP-332 activates “switches” inside cells that help the body produce and use energy more efficiently. It stimulates mitochondria (the body’s “power plants”), encourages the use of fat as fuel, and may make metabolism more active—especially in high energy–demand tissues such as muscle.
Key Benefits
More cellular energy: helps the body’s “power plants” (mitochondria) work more efficiently.
Greater use of fat as fuel: supports the body in using fat as an energy source.
More active metabolism: may increase daily energy expenditure without acting directly on appetite.
Metabolic adaptation: triggers signals in the body similar to periods of high energy demand (as if the body is in “performance mode”).
MOTS-C (40 mg Vial)
MOTS-c is a peptide produced by the mitochondrion (the cell’s “energy plant”). It is being studied for helping the body use energy more efficiently, by stimulating a pathway similar to the one activated by exercise and by metformin. As a result, it may support the use of fat for energy and improve the way muscles take up sugar (glucose).
Key Benefits
Insulin sensitivity: significantly improves how the body processes sugar, helping to counter insulin resistance.
Weight management: supports fat oxidation and may help prevent weight gain caused by high-fat diets.
Physical performance: increases endurance capacity and mitochondrial biogenesis (the creation of new cellular “power plants”).
Longevity and anti-ageing: its replenishment is associated with protection against degenerative diseases.
Bone health: studies suggest it may help prevent osteoporosis by promoting osteoblast differentiation.
Retatrutide (10mg Vial)
Retatrutide is a triple agonist of GLP-1, GIP, and glucagon. This combination works in an integrated manner to reduce appetite and increase satiety, improve glycaemic homeostasis, and promote greater energy expenditure/thermogenesis via activity at the glucagon receptor.
Key Benefits
Marked reduction in body weight in clinical studies, with high-impact results in obesity.
Improved glycaemic control and cardiometabolic markers (e.g., inflammatory lipids and blood pressure reported in readouts).
Reduced liver fat and improvements associated with metabolic liver disease (MASLD/MASH) in a Phase 2a study.
Quality of weight loss (body composition): evidence suggests a greater reduction in fat mass, without a disproportionate increase in lean mass loss, in body-composition sub-studies.
Tirzepatide (15mg Vial)
Tirzepatide is a dual agonist of GIP and GLP-1 receptors, acting in an integrated way across incretin pathways. It increases insulin secretion in a glucose-dependent manner and improves glycaemic regulation (reducing peaks and variability). It also acts on appetite/satiety centres, contributing to reduced food intake.
Key Benefits
Significant reduction in body weight in studies involving people with obesity/overweight (results depend on dose, duration, and adherence).
Robust improvement in glycaemic control (HbA1c) in people with type 2 diabetes, with dose-dependent reductions observed in clinical trials.
Cardiometabolic improvements associated with weight loss and incretin pathway activity.
Maintenance of weight loss with continued treatment, demonstrating sustained outcomes when use is maintained within protocol (in maintenance trials).
CJC-1295 (NO DAC) (5 mg) + Ipamorelin (5 mg)
A synergistic combination developed to stimulate the body’s natural release of growth hormone (GH) in a physiology-aligned way. By acting through two complementary pathways, it supports more consistent GH pulses and IGF-1 support, helping to sustain performance, recovery, and body composition.
Key Benefits
Stimulates the body’s own GH: helps the body release growth hormone in a pattern closer to natural physiology (in “pulses”).
Supports recovery and repair: may aid recovery (sleep, post-training, regeneration) by reinforcing GH/IGF-1–related signalling.
Body composition support: associated with a better balance between lean mass and fat, supporting body recomposition.
More efficient metabolism: may promote energy utilisation and support fat and protein metabolism.
Vitality and performance: many people seek a greater sense of energy and a steadier performance rhythm throughout the protocol.
